drugset / Trial / NCT00910065
BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to investigate whether intravenous administration (injected into a vein) of acetylsalicylic acid (Aspirin) in doses of 250 and 500 mg is superior to oral treatment of ACS with tablets containing 300 mg of Aspirin.
Timeline
- Start
- 2011-03
- Primary completion
- 2014-04
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 250 mg | Intravenous |
| Subject | Aspirin | Small molecule | 300 mg | Intravenous |
| Subject | Aspirin | Small molecule | 500 mg | Intravenous |